Half-life Extension Engineering
Half-Life Extension Engineering is a methodological framework in Fc engineering that specifically modulates the pharmacokinetic properties of therapeutic proteins by enhancing their serum persistence through targeted modifications of the Fc region to prolong systemic circulation.
16
Publications
617
Citations
162
Authors
48
Institutions
Publications per year
2017–2026
11
Parents
16
Half-life extension through albumin fusion technologies
Stefan Schulte · Thrombosis Research · 2009 · 67 citations
1–5 of 16
162
2
h-index
1
h-index
The University of Texas Medical Branch at Galveston, United States
1 publications · 17 citations
1
h-index
1
h-index
1
h-index
1–5 of 162
48

Aarhus University
Aarhus, Denmark
2 h-index
18 publications
746 citations
Technical University of Munich
Munich, Germany
1 h-index
2 publications
124 citations
US Biologic (United States)
Memphis, United States
1 h-index
2 publications
34 citations
Molecular Partners (Switzerland)
Schlieren, Switzerland
1 h-index
10 publications
910 citations

The University of Western Australia
Perth, Australia
1 h-index
25 publications
1.6K citations

Murdoch University
Perth, Australia
1 h-index
1 publications
62 citations
PYC Therapeutics (Australia)
Nedlands, Australia
1 h-index
23 publications
1.4K citations
The Kids Research Institute Australia
West Perth, Australia
1 h-index
23 publications
1.4K citations
1–8 of 48
3 publications · 65 citations
3
h-index
1 publications · 15 citations
1
h-index
1 publications · 61 citations
1
h-index
1 publications · 67 citations
1
h-index
PHCOA · 1 publications · 18 citations
1
h-index
1–5